BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2020 9:16:40 AM | Browse: 725 | Download: 1154
 |
Received |
|
2020-06-23 16:17 |
|
Peer-Review Started |
|
2020-06-23 16:17 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-07-25 20:30 |
|
Revised |
|
2020-08-01 21:01 |
|
Second Decision |
|
2020-09-08 12:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-09-08 20:38 |
|
Articles in Press |
|
2020-09-08 20:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-09-12 19:53 |
|
Typeset the Manuscript |
|
2020-09-21 00:27 |
|
Publish the Manuscript Online |
|
2020-09-24 09:16 |
| ISSN |
1949-8454 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Field of Vision |
| Article Title |
Immunological aspects of COVID-19: What do we know?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tsvetelina Veselinova Velikova, Stanislav Vasilev Kotsev, Daniel Stefanov Georgiev and Hristiana Momchilova Batselova |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tsvetelina Veselinova Velikova, MD, PhD, Assistant Professor, Department of Clinical Immunology, University Hospital Lozenetz, Kozyak 1 Street, Sofia 1407, Bulgaria. tsvelikova@medfac.mu-sofia.bg |
| Key Words |
SARS-CoV-2; COVID-19; Immune memory; Anti-SARS-CoV-2 antibodies; COVID-19 treatment; Plasma therapy |
| Core Tip |
Since the coronavirus disease 2019 (COVID-19) results from the interaction between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus and the individual′s immune system, we can assume that the onset and development significantly depend on this communication. Immunological aspects of the disease reflect the importance of the immune system to inhibit the viral factors, as well as to control and regulate the pathophysiological processes during SARS-CoV-2 infection. Moreover, immune-mediated and humoral immune responses, immune memory, the cytokine storm, neuroendocrine-immune regulation are critical factors that can determine the prognosis and the outcome for the patients. Now, the science is directed to acquiring new data on the immunology, including the immune memory against the virus, the development of new technologies for the detection of infection, and effective vaccines. However, the unclear points are much more than the verified knowledge of the SARS-CoV-2 virus and COVID-19. |
| Publish Date |
2020-09-24 09:16 |
| Citation |
Velikova TV, Kotsev SV, Georgiev DS, Batselova HM. Immunological aspects of COVID-19: What do we know? World J Biol Chem 2020; 11(2): 14-29 |
| URL |
https://www.wjgnet.com/1949-8454/full/v11/i2/14.htm |
| DOI |
https://dx.doi.org/10.4331/wjbc.v11.i2.14 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
